Early nephrology referral is associated with decreased mortality, hospitalizations, and better preparation for dialysis treatment.Indications for referral to nephrology include:

  • Acute kidney injury or abrupt decrease in GFR
  • GFR <30 mL/minute/1.73 m2 (G stage 4-5)
  • Persistent, significant albuminuria
  • Progression of CKD with sustained decline in GFR
  • Urinary red cell casts or urinary RBC >20 with no apparent explanation
  • CKD with hypertension that does not respond to 4 or more antihypertensive agents
  • Persistent serum potassium abnormalities
  • Recurrent or extensive nephrolithiasis
  • Hereditary kidney disease 2,8

Patients require a form of renal replacement therapy for survival once their GFR declines to 5 to 10 mL/minute/1.73 m3. The 3 forms of renal replacement therapy include hemodialysis, peritoneal dialysis, and renal transplant.5 The preferred form of hemodialysis access is the arteriovenous fistula, which may require months to mature before it can be used for hemodialysis. Therefore, it is recommended that patients with CKD establish care with a vascular surgeon within 1 year of requiring hemodialysis, so that construction may be attempted at least 6 months before they are expected to begin hemodialysis.15

How Can I Educate a Patient About Living With CKD?

Continue Reading

Patients should be aware of symptoms that may develop because of worsening CKD, such as swelling, hypertension, and fatigue. Providers should inform affected patients that they are at an elevated risk for heart disease, bone disease and fractures, anemia and abnormal blood clotting, and metabolic acidosis. Patients should be informed of the symptoms of uremic encephalopathy mentioned here, and call their clinician immediately after onset of symptoms.21

Providers should emphasize that treatment goals are based on preventing further damage to the kidneys; any existing damage cannot be reversed. Preventative measures include complying with antihypertensive and diabetic medications, as well as monitoring blood pressure and blood sugar appropriately. Dietary changes such as protein, fluid, and salt restrictions should be discussed, and alternative food options should be provided. Providers must counsel patients with CKD on weight loss and smoking cessation when appropriate. Patients must avoid taking nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen, and should consult with their physician before starting any new medication.21

Even in patients with early CKD, a discussion about future renal replacement therapy should occur. The advantages and disadvantages of each of their options should be reviewed so that patients can make an informed choice. Hemodialysis requires a major lifestyle change, as patients must spend hours at a dialysis center 3 times per week, and peritoneal dialysis requires filtration through the patient’s peritoneal membrane and is associated with peritonitis. Kidney transplant results in higher survival rates, but patients often must wait 2 to 6 years.5 Patients should already be in the care of a nephrologist by the time this decision is made, but it is important for primary providers to prepare patients for this early in the disease.

Related Articles


CKD remains a prevalent health issue in the United States and is associated with significant mortality and healthcare costs. Primary care providers play an essential role in identifying the disease early, providing preliminary patient education, and referring the patient to a specialist when appropriate. Clinicians must be aware of high-risk populations, including patients with diabetes mellitus, hypertension, heart disease, high body mass index, and advanced age.5 Patients with CKD are often asymptomatic; therefore, paying close attention to CKD clues on routine laboratory work and screening those with diabetes and hypertension may prevent delayed diagnosis. When a diagnosis of CKD is suspected, estimated GFR and albuminuria measurements must be properly obtained. Primary care providers should familiarize themselves with treatment strategies for CKD and medications that must be adjusted or avoided in patients with CKD, as well as educate patients on the detrimental effects of taking these medications without a clinician’s approval. Providers should not delay referral to nephrology, as early referral is associated with decreased mortality and hospitalizations for patients with CKD.

Natalie Wynn, PA-S, is a student and E. Rachel Fink, MPA, PA-C, is an assistant professor at Augusta University Physician Assistant Program in Georgia.


1. Saran R, Robinson B, Abbott KC, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3):A7-A8.

2. Levin A, Stevens PE, Bilous RW, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1).

3. Hu JR, Coresh J. The public health dimension of chronic kidney disease: what we have learnt over the past decade. Nephrol Dial Transplant. 2017;32(suppl_2):ii113-ii120.

4. Fatehi P, Hsu C. Diagnostic approach to the patient with newly identified chronic kidney disease. UpToDate website. https://www.uptodate.com/contents/diagnostic-approach-to-adult-patients-with-subacute-kidney-injury-in-an-outpatient-setting. Published October 26, 2017. Accessed November 15, 2019.

5. Papadakis MA, McPhee SJ, Rabow MW. Current Medical Diagnosis & Treatment 2017. 56th ed. New York: McGraw Hill Education; 2017.

6. Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;24(4):379-385.

7. Smart NA, Titus TT. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med. 2011;124(11):1073-1080.

8. Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M4, Sequist TD; National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med. 2016;129(2):153-162.

9. Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63(5):789-797.

10. Velasquez MT, Beddhu S, Nobakht E, Rahman M, Raj DS. Ambulatory blood pressure in chronic kidney disease: ready for prime time? Kidney Int Rep. 2016;1(2):94-104.

11. Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006;166(8):846-852.

12. Arici M. Management of Chronic Kidney Disease: A Clinician’s Guide. 1st ed. Berlin: Springer Berlin; 2016.

13. Levey AS, Inker LS. Definition and staging of chronic kidney disease in adults. UpToDate website. https://www.uptodate.com/contents/definition-and-staging-of-chronic-kidney-disease-in-adults. Updated November 26, 2018. Accessed November 15, 2019.

14. Tomson CR. Indications for renal biopsy in chronic kidney disease. Clin Med (Lond). 2003;3(6):513-517.

15. Rosenberg M. Overview of the management of chronic kidney disease in adults. UpToDate website. https://www.uptodate.com/contents/overview-of-the-management-of-chronic-kidney-disease-in-adults. Updated September 21, 2019. Accessed November 15, 2019.

16. Appel LJ, Wright JT, Greene T, et al; AASK Collaborative Research Group. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363(10):918-929.

17. Tsai WC, Wu HY, Peng YS, et al. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis. JAMA Intern Med. 2017;177(6):792-799.

18. Malhotra R, Nguyen HA, Benavente O, et al. Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5. JAMA Intern Med. 2017;177(10):1498-1505.

19. Kiernan MS, Udelson JE, Sarnak M, Konstam M. Cardiorenal syndrome: definition, prevalence, diagnosis, and pathophysiology. UpToDate website. https://www.uptodate.com/contents/cardiorenal-syndrome-definition-prevalence-diagnosis-and-pathophysiology. Updated January 15, 2018 Accessed November 15, 2019.

20. Raj Krishnamurthy VM, Wei Q, Baird BC, et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012;81(3):300-306.

21. Berns JS. Patient education: chronic kidney disease (beyond the basics). UpToDate website. https://www.uptodate.com/contents/chronic-kidney-disease-beyond-the-basics. Updated August 23, 2019. Accessed November 15, 2019.